Target intelligence / Profile preview

MBP antisense RNA 2 (MBP-AS2)

Target
MBP-AS2
Molecular classification
Non-coding RNA, Antisense RNA, Long non-coding RNA (lncRNA)
01

Overview

MBP antisense RNA 2 refers to a natural antisense transcript arising from the myelin basic protein (MBP) gene locus, characterized in certain mutant mouse models such as myelin-deficient (mld) mice. In these mice, a gene duplication and inversion event leads to robust expression of an antisense RNA overlapping the MBP gene. This antisense RNA is nuclear-localized and forms RNA:RNA duplexes with the sense MBP mRNA, likely resulting in either retention of the message in the nucleus or selective degradation, thereby suppressing production of MBP protein[1][4][5]. The biological significance of this antisense transcript appears to be post-transcriptional regulation of MBP expression through the formation of double-stranded RNA and effects on mRNA processing, but it is not a traditional drug target or receptor.\n\n*This target name does not conform to standard nomenclature, is not a canonical therapeutic target, and is not established in major pharmacological or protein classification systems. For these reasons, its use as a structured drug discovery target is incorrect or at minimum highly unconventional.*

Other names
MBP antisense RNAantisense MBP RNA
02

Mechanism of action

null

03

Biological functions

Post-transcriptional regulationRegulation of gene expressionRNA duplex formation with sense MBP mRNAPotential role in nuclear retention and mRNA degradation
04

Disease associations

Neurodevelopmental disorders (context: in mice, linked to hypomyelination and myelin-deficient phenotype)Other (since primary data are in mutant mouse models and not directly linked to human disease)

Beyond the preview

Go deeper on MBP antisense RNA 2 (MBP-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MBP antisense RNA 2 (MBP-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call